Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Marsh

Showing results (141-150 of 337) with videos related to

Pageof 34
Sort By:
Journal of Immunological Methods|October 4, 2011
High efficiency human memory B cell assay and its application to studying Plasmodium falciparum-specific memory B cells in natural infectionsGreta E Weiss, Francis M Ndungu, Noah McKittrick, et al.
Vaccine|June 27, 2013
A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malariaLinda M Murungi, Gathoni Kamuyu, Brett Lowe, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 9, 2019
Few Plasmodium falciparum merozoite ligand and erythrocyte receptor pairs show evidence of balancing selectionLynette Isabella Ochola-Oyier, Kevin Wamae, Irene Omedo, et al.
Malaria Journal|December 15, 2019
Use of gene expression studies to investigate the human immunological response to malaria infectionSusanne H Hodgson, Julius Muller, Helen E Lockstone, et al.
Plos One|May 1, 2008
Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in KenyansStephen M Todryk, Philip Bejon, Tabitha Mwangi, et al.
Pharmacoepidemiology and Drug Safety|March 9, 2019
Personalized benefit-risk assessments combining clinical trial and real-world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapyCathy Anne Pinto, Tommi Tervonen, Kevin Marsh, et al.
Headache|February 21, 2022
Patient preference for early onset of efficacy of preventive migraine treatmentsJessica Ailani, Paul Winner, Ann Hartry, et al.
Infection and Immunity|May 14, 2008
Plasmodium falciparum STEVOR proteins are highly expressed in patient isolates and located in the surface membranes of infected red blood cells and the apical tips of merozoitesJane E Blythe, Xue Yan Yam, Claudia Kuss, et al.
Plos One|January 10, 2013
Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in KenyaFrances Ibison, Ally Olotu, Daniel M Muema, et al.
Malaria Journal|August 19, 2008
Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1Claire L Mackintosh, Zoe Christodoulou, Tabitha W Mwangi, et al.
Pageof 34

Showing results (141-150 of 337) with videos related to

Sort By:
Pageof 34
Journal of Immunological Methods|October 4, 2011
High efficiency human memory B cell assay and its application to studying Plasmodium falciparum-specific memory B cells in natural infectionsGreta E Weiss, Francis M Ndungu, Noah McKittrick, et al.
Vaccine|June 27, 2013
A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malariaLinda M Murungi, Gathoni Kamuyu, Brett Lowe, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 9, 2019
Few Plasmodium falciparum merozoite ligand and erythrocyte receptor pairs show evidence of balancing selectionLynette Isabella Ochola-Oyier, Kevin Wamae, Irene Omedo, et al.
Malaria Journal|December 15, 2019
Use of gene expression studies to investigate the human immunological response to malaria infectionSusanne H Hodgson, Julius Muller, Helen E Lockstone, et al.
Plos One|May 1, 2008
Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in KenyansStephen M Todryk, Philip Bejon, Tabitha Mwangi, et al.
Pharmacoepidemiology and Drug Safety|March 9, 2019
Personalized benefit-risk assessments combining clinical trial and real-world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapyCathy Anne Pinto, Tommi Tervonen, Kevin Marsh, et al.
Headache|February 21, 2022
Patient preference for early onset of efficacy of preventive migraine treatmentsJessica Ailani, Paul Winner, Ann Hartry, et al.
Infection and Immunity|May 14, 2008
Plasmodium falciparum STEVOR proteins are highly expressed in patient isolates and located in the surface membranes of infected red blood cells and the apical tips of merozoitesJane E Blythe, Xue Yan Yam, Claudia Kuss, et al.
Plos One|January 10, 2013
Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in KenyaFrances Ibison, Ally Olotu, Daniel M Muema, et al.
Malaria Journal|August 19, 2008
Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1Claire L Mackintosh, Zoe Christodoulou, Tabitha W Mwangi, et al.
Pageof 34